GermanyOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 107 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16,414 | 16,308 |
| Total Cites | 23,020 | 25,842 |
| H-index | 78 | 85 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 228 | 265 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 4,495 | 4,917 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 12,928 | 14,174 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 18,978 | 20,002 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.29 |
| Self-Citation Percentage |
10.92%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 140 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19,567 | 19,299 |
| Total Cites | 19,384 | 21,851 |
| H-index | 72 | 78 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 190 | 221 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 4,175 | 4,575 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 11,047 | 12,138 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 15,991 | 16,897 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.29 |
| Self-Citation Percentage |
11.29%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 179 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22,239 | 21,481 |
| Total Cites | 16,424 | 18,631 |
| H-index | 67 | 73 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 171 | 202 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 3,900 | 4,294 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 9,466 | 10,471 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13,510 | 14,305 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.30 |
| Self-Citation Percentage |
11.85%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 209 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25,443 | 25,168 |
| Total Cites | 13,201 | 15,125 |
| H-index | 62 | 67 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 145 | 174 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 3,544 | 3,916 |
| Number of Single+First+Last Authored Papers | 87 | 87 |
| Total Cites to Single+First+Last Authored Papers | 7,708 | 8,605 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,870 | 11,570 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.31 |
| Self-Citation Percentage |
12.72%
|
|
NetherlandsOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 231 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27,033 | 25,942 |
| Total Cites | 11,932 | 13,798 |
| H-index | 58 | 64 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 136 | 165 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 3,363 | 3,735 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 6,989 | 7,862 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,831 | 10,500 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.31 |
| Self-Citation Percentage |
13.52%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 320 out of 94,611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36,698 | 34,941 |
| Total Cites | 8,681 | 10,217 |
| H-index | 48 | 52 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 118 | 145 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 2,919 | 3,273 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 5,198 | 5,977 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,196 | 7,739 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.32 |
| Self-Citation Percentage |
15.03%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Germany10,666 scientists, 4th in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.